Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 2, 2014, Pages 102-109

  Sheikhbahaei, Sara ^a   Fotouhi, Akbar ^b   Hafezi Nejad, Nima ^a   Nakhjavani, Manouchehr ^a   Esteghamati, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URIC ACID; YOUNG ADULT;

EID: 84894436419     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0119     Document Type: Article

References (45)

1. Esteghamati A, Khalilzadeh O, Anvari M, et al. The economic costs of diabetes: A population-based study in Tehran, Iran. Diabetologia 2009;52:1520-1527
2. Standards of medical care in diabetes-2012. Diabetes Care 2012;35(Suppl 1):S11-S63
3. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999;341:1127-1133
4. Jalal DI, Maahs DM, Hovind P, et al. Uric acid as a mediator of diabetic nephropathy. Semin Nephrol 2011;31: 459-465
5. Soltani Z, Rasheed K, Kapusta DR, et al. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: Is it time for reappraisal?. Curr Hypertens Rep 2013;15:175-181
6. Laguardia HA, Hamm LL, Chen J. The metabolic syndrome and risk of chronic kidney disease: Pathophysiology and intervention strategies. J Nutr Metab 2012;2012: 652608
7. Johns BR, Pao AC, Kim SH. Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transplant 2011;27:1410-1415
8. Luk AO, So WY, Ma RC, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008;31: 2357-2361
9. Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013;22: 198-203
10. Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438
11. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23: 469-480
12. Hovind P, Rossing P, Tarnow L, et al. Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: An inception cohort study. Diabetes 2009;58: 1668-1671
13. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-2897
14. Sui X, Church TS, Meriwether RA, et al. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008;57:845-852
15. Zhang ML, Gao YX, Wang X, et al. Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults. J Clin Biochem Nutr 2013; 52:38-42
16. Nashar K, Fried LF. Hyperuricemia and the progression of chronic kidney disease: Is uric acid a marker or an independent risk factor?. Adv Chronic Kidney Dis 2012;19: 386-391
17. Zoppini G, Targher G, Chonchol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care 2012;35:99-104
18. See LC, Kuo CF, Chuang FH, et al. Hyperuricemia and metabolic syndrome: Associations with chronic kidney disease. Clin Rheumatol 2010;30:323-330
19. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
20. Chen LY, Zhu WH, Chen ZW, et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B 2007;8:593-598
21. Goncalves JP, Oliveira A, Severo M, et al. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 2012;41:450-457
22. Lin WY, Liu CS, Li TC, et al. In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: A population-based study (Taichung Community Health Study). Ann Rheum Dis 2008;67:432-433
23. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120: 442-447
24. Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 2013;25:210-216
25. PacificoL,Cantisani V,Anania C, et al. Serumuric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrinol 2009;160:45-52
26. Yang T, Chu CH, Bai CH, et al. Uric acid level as a risk marker for metabolic syndrome: A Chinese cohort study. Atherosclerosis 2011;220:525-531
27. Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res 2006;37:883-889
28. Hongo M, Hidaka H, Sakaguchi S, et al. Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students. Circ J 2010;74:1570-1577
29. Hairong N, Zengchang P, Shaojie W, et al. Serum uric acid, plasma glucose and diabetes. Diab Vasc Dis Res 2010;7:40-46
30. Kawamoto R, Tabara Y, Kohara K, et al. Serum uric acid is more strongly associated with impaired fasting glucose in women than in men from a community-dwelling population. PLoS One 2013;8:e65886
31. Liu PW, Chang TY, Chen JD. Serum uric acid and metabolic syndrome in Taiwanese adults. Metabolism 2010; 59:802-807
32. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761
33. Tsouli SG, Liberopoulos EN, Mikhailidis DP, et al. Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander?. Metabolism 2006;55:1293-1301
34. Reimann M, Schutte AE, Malan L, et al. Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: A factor analysis. Atherosclerosis 2008;197:638-645
35. Dai X, Yuan J, Yao P, et al. Association between serum uric acid and the metabolic syndrome among a middle- And old-Age Chinese population. Eur J Epidemiol 2013;28: 669-676
36. Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005;68:796-801
37. Rodilla E, Perez-Lahiguera F, Costa JA, et al. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients. Med Clin (Barc) 2009;132:1-6
38. Tanner RM, Brown TM, Muntner P. Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep 2012;14:152-159
39. Tsioufis C, Chatzis D, Vezali E, et al. The controversial role of serum uric acid in essential hypertension: Relationships with indices of target organ damage. J Hum Hypertens 2005;19:211-217
40. Viazzi F, Parodi D, Leoncini G, et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005;45:991-996
41. Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24:691-697
42. Jalal DI, Rivard CJ, Johnson RJ, et al. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: Findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant 2010;25:1865-1869
43. Kanbay M, Huddam B, Azak A, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 2011; 6:1887-1894
44. Yelken B, Caliskan Y, Gorgulu N, et al. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol 2012;77:275-282
45. Klausen KP, Parving HH, Scharling H, et al. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: Impact on cardiovascular disease and mortality. J Intern Med 2007;262:470-478